LISA SHAMBLIN: Open Payments
NPI 1497996177 · GRAPEVINE, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$115,874 in 176 payments from 5 companies in 2025. Trend: 2023 $197 · 2024 $43,924 · 2025 $115,874
Speaker / faculty: $81,649Travel & lodging: $22,426Consulting: $8,749Food & beverage: $3,051
| Company | Payments | Amount |
|---|---|---|
| E.R. Squibb & Sons, L.L.C. | 84 | $68,886 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 84 | $46,468 |
| Alkermes, Inc. | 5 | $331 |
| Otsuka America Pharmaceutical, Inc. | 1 | $102 |
| Neurocrine BioSciences, Inc. | 2 | $88 |
Products named: COBENFY, CAPLYTA, LYBALVI, REXULTI, INGREZZA, ARISTADA.
Industry payments across TX — which companies pay providers there.
